Protara Therapeutics Inc [TARA] stock prices are down -0.43% to $4.60 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TARA shares have gain 6.73% over the last week, with a monthly amount glided 16.46%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On June 04, 2021, H.C. Wainwright initiated with a Buy rating and assigned a price target of $40 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $43 on February 17, 2021. Cowen initiated its recommendation with a Outperform and recommended $50 as its price target on October 19, 2020. Guggenheim started tracking with a Buy rating for this stock on July 29, 2020, and assigned it a price target of $50.
The stock price of Protara Therapeutics Inc [TARA] has been fluctuating between $1.60 and $10.48 over the past year. Protara Therapeutics Inc [NASDAQ: TARA] shares were valued at $4.60 at the most recent close of the market.
Analyzing the TARA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.45 and Total Capital is -0.29. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.43 points at the first support level, and at 4.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.72, and for the 2nd resistance point, it is at 4.84.
Ratios To Look Out For
It’s worth pointing out that Protara Therapeutics Inc [NASDAQ:TARA]’s Current Ratio is 15.71. As well, the Quick Ratio is 15.71, while the Cash Ratio is 14.85.
Transactions by insiders
Recent insider trading involved Opaleye Management Inc., 10% Owner, that happened on Sep 12 ’24 when 0.13 million shares were sold. 10% Owner, Opaleye Management Inc. completed a deal on Sep 11 ’24 to sell 32600.0 shares. Meanwhile, 10% Owner Opaleye Management Inc. sold 36492.0 shares on Sep 09 ’24.
